REXALL FEMININE MAXIMUM STRENGTH ANTI-ITCH (Dolgencorp, Inc.)
Welcome to the PulseAid listing for the REXALL FEMININE MAXIMUM STRENGTH ANTI-ITCH drug offered from Dolgencorp, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Dolgencorp, Inc. |
NON-PROPRIETARY NAME: | Benzocaine and Resorcinol |
SUBSTANCE NAME: | BENZOCAINE; RESORCINOL |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | CREAM |
MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
START MARKETING DATE: | 2016-09-27 |
END MARKETING DATE: | 0000-00-00 |
REXALL FEMININE MAXIMUM STRENGTH ANTI-ITCH HUMAN OTC DRUG Details:
Item Description | REXALL FEMININE MAXIMUM STRENGTH ANTI-ITCH from Dolgencorp, Inc. |
LABELER NAME: | Dolgencorp, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20; 3(g/100g; g/100g) |
START MARKETING DATE: | 2016-09-27 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 55910-415_3d941002-457d-304e-e054-00144ff8d46c |
PRODUCT NDC: | 55910-415 |
APPLICATION NUMBER: | part346 |
Other BENZOCAINE; RESORCINOL Pharmaceutical Manufacturers / Labelers: